Latest Dementia with Lewy bodies Stories
A method of classifying brain atrophy patterns in Alzheimer's disease patients using MRIs can also detect cognitive decline in Parkinson's disease.
As Parkinson's Awareness Month gets underway, a Canadian-led international study is providing important new insight into Parkinson's disease and paving the way for new avenues for clinical trials.
A new study shows that a sleep disorder may be a sign of dementia or Parkinson's disease up to 50 years before the disorders are diagnosed.
NEW YORK, May 11 /PRNewswire-USNewswire/ -- The Alzheimer's Drug Discovery Foundation (ADDF) and the Lewy Body Dementia Association (LBDA) announced today the recipient of their first partnership research award through the Lewy Body Dementia Biomarker Research Program.
NEW YORK, Dec. 15 /PRNewswire-USNewswire/ -- The Michael J. Fox Foundation announced $1.7 million in funding to drive new and continuing Parkinson's research projects at the Banner Sun Health Research Institute and Mayo Clinic Arizona, sites of the Arizona Parkinson's Disease Consortium.
Both genetic and pathologic data indicate a role for the neuronal protein alpha-synuclein in Parkinson disease.
A report on Thursday over the ethical dilemmas of dementia said that millions of people suffering with the brain-wasting disease are often left without care or support until their illness reaches a crisis point.
CHICAGO, Aug. 27 /PRNewswire/ -- The British Midlands Development Corporation today announced that scientists at The University of Nottingham have made a crucial breakthrough in the battle to slow or prevent the onset of a very common type of dementia and Parkinson's disease.
By KELLY SHORROCK Dementia patients have welcomed the news that drugs which could slow or prevent the onset of the condition could be available in as little as eight years' time.
- A person in a secondary role, specifically the second most important character (after the protagonist).